Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD)
NCT ID: NCT02084758
Last Updated: 2017-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-09-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
NCT04231760
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
NCT01739790
The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD
NCT03679312
Nutritional Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Muscle Atrophy
NCT01344135
Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction
NCT02579772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nitrate supplementation
Sodium nitrate solution
Nitrate supplementation
7 days of supplementation with sodium nitrate solution
Placebo supplementation
7 days of supplementation with sodium chloride solution
Placebo supplementation
Sodium chloride solution
Nitrate supplementation
7 days of supplementation with sodium nitrate solution
Placebo supplementation
7 days of supplementation with sodium chloride solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nitrate supplementation
7 days of supplementation with sodium nitrate solution
Placebo supplementation
7 days of supplementation with sodium chloride solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication metabolic inefficiency
Exclusion Criteria
* Long-term oxygen therapy
* Severe renal impairment
* Use of medications that may interact with nitrate
* Contra-indications for performing (sub)maximal cycle ergometry
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annemie Schols, Prof.
Role: STUDY_DIRECTOR
Maastricht University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABR-47701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.